Phillips Andrew John

Phillips Andrew John is listed in filings as Director at OnKure Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 9, 2025, including 4 public disclosures. Recent filings connect the profile to OnKure Therapeutics, Inc. (OKUR), MoonLake Immunotherapeutics (MLTX), and Enliven Therapeutics, Inc. (ELVN). The current snapshot covers public activity from Oct 8, 2024 to Jun 9, 2025. Reported amounts are shown as $278.5K to $326.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.